Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
12 hedge funds and large institutions have $6.69M invested in Yield10 Bioscience, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
9% more funds holding
Funds holding: 11 → 12 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
63% less capital invested
Capital invested by funds: $18.2M → $6.69M (-$11.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FA
FCG Advisors
Chatham,
New Jersey
|
+$77K |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$25.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$513K |
YTEN Hedge Fund Activity: Q3 2015 in Review
12 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q3 2015, worth a combined $6.69M — down 63% from $18.2M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new YTEN positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was FCG Advisors, adding an estimated $77K. The largest seller was Oracle Investment Management, cutting an estimated $513K.
- 12 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q3 2015, up from 11 in Q2 2015.
- Funds reported $6.69M of Yield10 Bioscience, Inc. Common Stock stock for Q3 2015, down 63% quarter-over-quarter.
- 1 fund opened new Yield10 Bioscience, Inc. Common Stock positions in Q3 2015 and 0 closed out, a net change of +1 holder.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q3 2015 was FCG Advisors, an estimated $77K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q3 2015 was Oracle Investment Management, an estimated $513K sold.
Based on aggregated 13F filings for Q3 2015.